Barrett's Esophagus Translational Research Network (BETRNet)
The Barrett’s Esophagus Translational Research Network (BETRNet) is a program (supported by DCB and the NCI Division of Cancer Prevention through RFA-CA-16-006/RFA-CA-16-007) that was established to address the rising incidence of esophageal adenocarcinoma in the United States.
BETRNet objectives are to achieve a better understanding of esophageal adenocarcinoma biology, examine research opportunities associated with its precursor lesion Barrett’s Esophagus, and improve prevention of esophageal cancers.
BETRNet Patient Registry with Virtual Biorepository
BETRNet created a catalog of Barrett’s esophagus and esophageal adenocarcinoma bio-specimens available for research purposes. Additional information can be found at the Biorepository website.
BETRNet Digital Media
Additional information about the program can be found at websites created by BETRNet centers:
DCB Contact for BETRNet
For additional information about BETRNet, please contact Dr. Rihab Yassin.
Funded Projects
Institution | Principal Investigator(s) | Project Title |
---|---|---|
Case Western Reserve University |
Amitabh Chak, Kishore Guda |
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma |
Columbia University Health Sciences | Julian Abrams, Anil K. Rustgi, Kenneth K. Wang | The Role of the Microenvironment in Barrett's Esophagus |
University of Michigan |
Thomas D. Wang, Joel H. Rubenstein |
Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma |
Vanderbilt University Medical Center |
Yu Shyr |
Barrett's Esophagus Translational Research Network Coordinating Center (BETRNetCC) |